Spravato vs. Ketamine Infusion: What’s the Difference?
Depression affects over 280 million people worldwide. Meanwhile, 30% of people diagnosed with major depressive disorder experience treatment-resistant depression. This means they struggle to find relief (or find none at all) with traditional mental health treatments. For those battling treatment-resistant depression, innovative solutions like Spravato™ (esketamine) and ketamine infusions offer renewed hope. But what’s the …